Moreover, polydatin treatment significantly mitigated the AGEs-induced overexpression of transforming growth factor-beta 1 (TGF-β1) and fibronectin, both of which are pivotal in the fibrotic processes associated with diabetic nephropathy [17]. This evidence concerns the gene TGFB1 and diabetic kidney disease.